Kajian klinikal COPD di Nevada
8 kajian untuk COPD sedang mencari peserta di lokasi di Nevada.
Bandar di Nevada
Teks kajian rasmi (Bahasa Inggeris)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Las Vegas
- Research Site, Las Vegas
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Excel Clinical Research - Las Vegas- Site Number : 8400070, Las Vegas
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Henderson Clinical Trials- Site Number : 8400026, Henderson
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Las Vegas
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Henderson Clinical Trials, Henderson
Mengambil pesertaFasa 2/3
Umur 35 hingga 80 · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07363694eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Henderson
- GSK Investigational Site, Las Vegas
- GSK Investigational Site, Reno
Mengambil pesertaFasa 3
Umur 40 hingga 75 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Las Vegas
Mengambil pesertaFasa 3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Renown Regional Medical Center, Reno
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.